- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Thyrocare has announced a board meeting to approve the grant of 2,823 stock options to eligible employees of its subsidiary under the Thyrocare Employees Stock Option Scheme. Each option is priced at ₹10 and will vest between one to three years from the grant date, with a maximum exercise period of seven years following vesting. This initiative aims to incentivize employee performance and align their interests with those of shareholders. Investors might view this positively as it could enhance employee motivation and retention, potentially driving future growth and operational success.